ClinicalTrials.govpublic full text
Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Mid-low Locally Advanced Rectal Cancer - a Single-center, Single-arm, Open-label Clinical Trail
locally advanced rectal adenocarcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 180391
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.